Philip Kantoff is the founder of Convergent Therapeutics. Convergent Therapeutics has raised $90M in total funding. Latest round: Series A.
Philip Kantoff, MD, is the Co-Founder and Chief Executive Officer of Convergent Therapeutics. He is an oncologist with 28 years of experience, previously building genitourinary oncology at Dana-Farber and running medicine at Memorial Sloan Kettering before founding Convergent Therapeutics in 2021. Under his leadership, Convergent secured $90 million in Series A financing and received FDA clearance for clinical studies.
Full founder directory · Investor directory · Company funding database · Fundraising library